"Shock" breakthrough in prostate cancer, and it isn't from tiny Dendreon (DNDN).

Discussion in 'Stocks' started by wilburbear, Jun 20, 2009.

  1. m22au


    First of all, thanks to Wilburbear for the post above.

    Second, another way to "play" the news is with the relevant biotech company,


    Ipilimumab is one of a class of drugs called monoclonal antibodies, which stimulate the body's own immune system to fight disease. The experimental treatment is being developed by Bristol-Myers Squibb and Medarex, a US biotech company.
  2. Medarex could be one of those small bio-tech stocks that is "in play".